MedPath

The effect of Donepezil on Depressio

Phase 3
Conditions
Majore Depressive.
Severe depressive episode with psychotic symptoms
Registration Number
IRCT2015092824236N1
Lead Sponsor
Vice Chancellor for Research of Shahid Sadoughi University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
76
Inclusion Criteria

Patients in the age range 30 to 40 years, Complete the consent form, with major Depression according to the text of the revised fourth edition of Diagnostic and Statistical Manual of Mental Disorders, Treated with selective Serotonin reuptake inhibitors, Two months after receiving Antidepressant assessment exam Montreal is less than 26.
Exclusion criteria: At the same time suffering from major Depression and other mental disorders. At the same time suffering from major Depression and a physical disorder with features of cognitive impairment including Alzheimer or other degenerative neurological disorders, head injuries or Hypothyroidism. Concomitant use of Anticholinergic agents and nervous system Depressant drugs

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Major Depressive Disorder. Timepoint: 2 months after drug consumption. Method of measurement: Montreal Cognitive assessment test.
Secondary Outcome Measures
NameTimeMethod
Drug side effects. Timepoint: 2 months after drug consumption. Method of measurement: Examination and test results.
© Copyright 2025. All Rights Reserved by MedPath